Zymeworks (ZYME) Receivables (2021 - 2026)
Zymeworks (ZYME) reported Receivables of $5.93 million for Q2 2026, up 125.4% from $2.63 million a year earlier and up 26.9% from the prior quarter.
Powered by 
Analysis
Zymeworks (ZYME) Receivables (2021 - 2026) Analysis & Trends
At the end of FY2025, Zymeworks posted Receivables of $4.64 million, down 91.7% from FY2024.
- Receivables has a four-year compound annual growth rate of -26.2% (FY2021 to FY2025).
- By year, Receivables came in at $55.82 million in FY2024 (+186.6%), $19.48 million in FY2023 (-41.7%), $33.4 million in FY2022 (+113.9%) and $15.61 million in FY2021.
- Five-year quarterly Receivables spans a low of $2.63 million in Q2 2025 and a high of $67.27 million in Q3 2023.
- Year over year, Receivables gained in three of the last eight quarters, with an average decline of 1.7%.
- The high point for year-over-year Receivables in five years was Q3 2023 (growth of 899.9%); the low point was Q2 2025 (a decline of 91.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $4.67 million (Q1 2026), $4.64 million (Q4 2025) and $29.35 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Zymeworks | 1.94 Bn | 820.54 Mn | - | 5.93 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.93 Mn |
| Mar 31, 2026 | 4.67 Mn |
| Dec 31, 2025 | 4.64 Mn |
| Sep 30, 2025 | 29.35 Mn |
| Jun 30, 2025 | 2.63 Mn |
| Mar 31, 2025 | 24.59 Mn |
| Dec 31, 2024 | 55.82 Mn |
| Sep 30, 2024 | 23.70 Mn |
| Jun 30, 2024 | 32.08 Mn |
| Mar 31, 2024 | 30.95 Mn |
| Dec 31, 2023 | 19.48 Mn |
| Sep 30, 2023 | 67.27 Mn |
| Jun 30, 2023 | 48.82 Mn |
| Mar 31, 2023 | 66.92 Mn |
| Dec 31, 2022 | 33.40 Mn |
| Sep 30, 2022 | 6.73 Mn |
| Dec 31, 2021 | 15.61 Mn |
API Access
Zymeworks Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=ZYME&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "ZYME", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=ZYME&period=max&api_key=YOUR_API_KEY");
const data = await res.json();